REGISTERED
on 09 Jul 2024
Last Applicant/ Owned by
Oxford Science Park
Oxford
GB
OX44GA
Serial Number
98015655 filed on 26th May 2023
Registration Number
7437796 registered on 09th Jul 2024
Correspondent Address
Patrice P. Jean
Filing Basis
No Filing Basis
Disclaimer
NO DATA
INGENOX
biochemical research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylatio Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
biochemical research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and/or cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; consultancy, advisory and/or information services relating to or connected with the aforementioned services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; inhibitors of arginine methylation for the treatment of cancer; inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; compounds for the treatment, diagnosis, detection and/or prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98015655
Mark Type
No Service Mark
Attorney Docket Number
No 033569-00001
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
01.09.05 -
Atoms or molecular models
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Jul 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 09th Jul 2024 | REGISTERED-PRINCIPAL REGISTER |
| 23rd Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 23rd Apr 2024 | PUBLISHED FOR OPPOSITION |
| 03rd Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 13th Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 13th Mar 2024 | EXAMINER'S AMENDMENT ENTERED |
| 13th Mar 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 13th Mar 2024 | EXAMINERS AMENDMENT E-MAILED |
| 13th Mar 2024 | EXAMINERS AMENDMENT -WRITTEN |